Company news
Processa Pharmaceuticals, Inc. news in 2022
Processa Pharmaceuticals, Inc.'s news releases, calls and decks from 2022, newest first.
Processa Pharmaceuticals Announces PCS12852 Successfully Improves the Clinical Symptoms Associated with Gastroparesis in Phase 2A Trial
December 13, 2022
Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update
November 7, 2022
Processa Successfully Identifies Next Generation Capecitabine Dosage Regimens for Phase 2B Trial
October 31, 2022
Processa Pharmaceuticals Provides Update on Enrollment Across all Clinical Programs
September 14, 2022
Processa Pharmaceuticals Appoints Khoso Baluch and James Neal to its Board of Directors and Justin Yorke to Chairman of the Board
August 15, 2022
Processa Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate Update
August 11, 2022
Processa Pharmaceuticals to Host Conference Call to Discuss Its Second Quarter 2022 Results and Provide 2nd Half Clinical Pipeline Update on August 11, 2022, at 4: 30 p.m. EST
August 4, 2022
Processa Pharmaceuticals Announces Launch of Website (www.Necrobiosislipoidicastudy.com) to Increase Awareness of Ulcerative Necrobiosis Lipoidica and to Inform Patients of the ongoing Phase 2B Study of PCS499
August 2, 2022
Processa Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Corporate Update
May 11, 2022
Processa Pharmaceuticals Doses First Patient in Amended Phase 1B Protocol for PCS6422 Combined with Capecitabine (Next Generation Capecitabine)
April 19, 2022
Processa Pharmaceuticals Announces First Patient Enrolled in the PCS12852 Phase 2A Trial for the Treatment of Gastroparesis
April 4, 2022
Processa Pharmaceuticals Announces Year-End 2021 Results and Provides Corporate Update
March 29, 2022
Processa Pharmaceuticals To Host Conference Call to Discuss Fourth Quarter 2021 Results and Provide Drug Development Update on March 30 at 4: 30 p.m. EST
March 22, 2022
Calls in 2022
- Processa Pharmaceuticals (NASDAQ:PCSA) Q3 2022 Earnings Call
Nov 8, 2022
Transcript - Processa Pharmaceuticals (NASDAQ:PCSA) Q2 2022 Earnings Call
Aug 11, 2022
Transcript - Processa Pharmaceuticals (NASDAQ:PCSA) Q1 2022 Earnings Call
May 12, 2022
Transcript - Processa Pharmaceuticals (NASDAQ:PCSA) Q4 2021 Earnings Call
Mar 30, 2022
Transcript
Decks in 2022
- Investor Presentation (December 2022)
Investor deck · 39 slides · Dec 22, 2022
- Q3 2022 Earnings Presentation
Earnings · 20 slides · Nov 8, 2022
- Investor Presentation (September 2022)
Investor deck · 24 slides · Sep 7, 2022
- Corporate Update (August 2022)
Corporate update · 28 slides · Aug 12, 2022
- Corporate Update (May 2022)
Corporate update · 40 slides · May 12, 2022
- Corporate Update (March 2022)
Corporate update · 27 slides · Mar 17, 2022